Author

Edouard Louis

MRI EVOLUTION AND EFFICACY OF BONE MARROW-DERIVED MESENCHYMAL STEM CELLS IN PERIANAL FISTULAE IN CROHN’S DISEASE: RESULTS FROM A PROSPECTIVE MONOCENTRIC STUDY
MRI EVOLUTION AND EFFICACY OF BONE MARROW-DERIVED MESENCHYMAL STEM CELLS IN PERIANAL FISTULAE IN CROHN’S DISEASE: RESULTS FROM A PROSPECTIVE MONOCENTRIC STUDY

Edouard Louis  et al.

LOCAL MESENCHYMAL STEM CELLS INJECTION IN CROHN’S DISEASE STRICTURES: A PHASE I-II CLINICAL STUDY
LOCAL MESENCHYMAL STEM CELLS INJECTION IN CROHN’S DISEASE STRICTURES: A PHASE I-II CLINICAL STUDY

Edouard Louis  et al.

CLINICALLY ADJUSTED VERSUS THERAPEUTIC DRUG MONITORING DOSING REGIMENS WITH ADALIMUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: RESULTS FROM THE SERENE-CD MAINTENANCE STUDY
CLINICALLY ADJUSTED VERSUS THERAPEUTIC DRUG MONITORING DOSING REGIMENS WITH ADALIMUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: RESULTS FROM THE SERENE-CD MAINTENANCE STUDY

Edouard Louis  et al.

EFFECT OF RISANKIZUMAB TREATMENT ON EXTRAINTESTINAL MANIFESTATIONS (EIMS) IN PATIENTS WITH MODERATE TO SEVERE CROHN’S DISEASE (CD): RESULTS FROM THE ADVANCE, MOTIVATE AND FORTIFY STUDIES
EFFECT OF RISANKIZUMAB TREATMENT ON EXTRAINTESTINAL MANIFESTATIONS (EIMS) IN PATIENTS WITH MODERATE TO SEVERE CROHN’S DISEASE (CD): RESULTS FROM THE ADVANCE, MOTIVATE AND FORTIFY STUDIES

Edouard Louis  et al.

Item 21 - 24 / 24
1
2